We are live on ! Find out more
CYTR

CytRx Corp
CYTR

Delisted

CYTR was delisted on the 3rd of June, 2019.

71 hedge funds and large institutions have $52.8M invested in CytRx Corp in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 12

12% more capital invested

Capital invested by funds: $47.3M → $52.8M (+$5.52M)

3% more funds holding

Funds holding: 6971 (+2)

1.2% more ownership

Funds ownership: 37.65%38.85% (+1.2%)

15% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 20

58% less call options, than puts

Call options by funds: $278K | Put options by funds: $665K

Holders
71
Holders Change
+2
Holders Change %
+2.9%
% of All Funds
1.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
17
Reduced
20
Closed
12
Calls
$278K
Puts
$665K
Net Calls
-$387K
Net Calls Change
-$818K

CYTR Hedge Fund Activity: Q4 2014 in Review

71 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in CytRx Corp (CYTR) for Q4 2014, worth a combined $52.8M — up 12% from $47.3M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CYTR positions and 12 closed out — a net gain of 5 holders — while 17 added to existing stakes and 20 trimmed.

The largest buyer was QVT Financial, adding an estimated $1.85M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $3.38M sold.

  • 71 institutional investors held CytRx Corp (CYTR) as of Q4 2014, up from 69 in Q3 2014.
  • Funds reported $52.8M of CytRx Corp stock for Q4 2014, up 12% quarter-over-quarter.
  • 17 funds opened new CytRx Corp positions in Q4 2014 and 12 closed out, a net change of +5 holders.
  • The largest CytRx Corp buyer in Q4 2014 was QVT Financial, an estimated $1.85M added.
  • The largest CytRx Corp seller in Q4 2014 was JP Morgan Chase, an estimated $3.38M sold.

Based on aggregated 13F filings for Q4 2014.